Used in the synthesis of protease inhibitors, particularly in the development of pharmaceuticals targeting viral proteases such as those in hepatitis C and HIV. Its chiral hydroxy amino acid structure serves as a key building block for constructing transition-state mimetics that enhance inhibitor potency and selectivity. Also employed in peptidomimetic research to improve metabolic stability and bioavailability of peptide-based drugs.